MAPK/ERK


The mitogen-activated protein kinase (MAPK) is a highly conserved family of serine/threonine kinases that mediate a board range of cellular processes, including proliferation, differentiation, motility, migration, stress response, apoptosis and survival. The activation of MAPK involves signaling pathways consisting of MAPK kinase (i.e. MAPKKK or MEKK) that activates MAPK/ERK (i.e. MAPKK or MEK). A variety of extracellular signals such as mitogens, cytokines, growth factors, and environmental stressors stimulate a phosphorylation-dependent increase in the activity of MAPK.
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
-
C5850 SD 1692 CitationSummary: selective ATP competitive inhibitor of the MAP kinases p38α and p38β -
A8780 WM-2474Summary: Inactive analogue of WM-8014, used as control compound -
B8309 CyclosporinSummary: A class of cyclic decapeptide compounds produced by soil fungi, whose primary targets of action are the cyclophilin family. -
B8388 ERK5-in-1 -
B7820 APS-2-79Summary: KSR-dependent MAPK modulator -
A1117 PKA inhibitor fragment (6-22) amideSummary: PKA inhibitor -
C3921 Ulixertinib (hydrochloride)Summary: reversible ERK1/2 inhibitor -
C3728 Sp-5,6-dichloro-cBIMPS (sodium salt)Summary: PKA activator -
C4338 AG-1262 CitationSummary: ERK1 (p44) and ERK2 (p42) inhibitor -
C4361 PD 184161Summary: MEK1/2 inhibitor

